The global prostate cancer therapeutics market is estimated to grow at a CAGR of 10.2% during the forecast period. The major factors that are primarily driving the market growth include a significant prevalence of prostate cancer that increases the demand for efficient therapies for the treatment of cancer. For instance, as per the World Cancer Research Fund (WCRF), prostate cancer is the second most commonly occurring cancer in men and the fourth most commonly occurring cancer overall. There were 1.3 million new cases of prostate cancer were reported across the globe in 2018.
Moreover, increasing the adoption of innovative technologies for the diagnosis of prostate cancer is expected to fuel market growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. Cancer, if diagnosed, needed to be treated in order to improve quality of life of the patient; thereby, spurs the market growth. Further, players operating in the market are investing in R&D for the development of new therapeutics to treat such tumors, which further fuels the growth of the global prostate cancer therapeutics industry.
Segment Outlook
The global prostate cancer therapeutics market is segmented on the basis of therapy. The report covers the study of major drugs that are classified into four major therapies including hormonal therapy, chemotherapy, immunotherapy, and targeted therapy. The increasing number of drugs in pipeline is expected to spur the growth of the market in the near future.
Global Prostate Cancer Therapeutics Market Share by Therapy, 2018 (%)
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
1.2.3. Key Findings
1.2.4. Recommendations
1.2.5. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Sanofi S.A.
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Astellas Pharma, Inc.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Bayer AG
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Johnson & Johnson Services, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. AstraZeneca PLC
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Prostate Cancer Therapeutics Market by Therapy
5.1.1. Hormonal Therapy
5.1.2. Chemotherapy
5.1.3. Immunotherapy
5.1.4. Radiation Therapy
5.1.5. Targeted Therapy
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. AbbVie, Inc.
7.3. Amgen, Inc.
7.4. Anixa Biosciences, Inc.
7.5. Astellas Pharma, Inc.
7.6. AstraZeneca PLC
7.7. Bavarian Nordic A/S
7.8. Bayer AG
7.9. Bristol-Myers Squibb Co.
7.10. Decipher Biosciences, Inc.
7.11. F. Hoffmann-La Roche Ltd.
7.12. Ferring B.V.
7.13. General Electric Co.
7.14. GlaxoSmithKline PLC
7.15. Ipsen Group
7.16. Johnson & Johnson Services, Inc.
7.17. MDNA Life Sciences, Inc.
7.18. Merck KGaA
7.19. miR Scientific, LLC
7.20. Myriad Genetics, Inc.
7.21. Nanostics Inc.
7.22. Novartis AG
7.23. Pfizer, Inc.
7.24. Sanofi S.A.
7.25. Siemens Healthcare AG
1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
2. GLOBAL HORMONAL THERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL CHEMOTHERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL IMMUNOTHERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL RADIATION THERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL TARGETED THERAPY FOR PROSTATE CANCER MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
7. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
8. NORTH AMERICAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
9. NORTH AMERICAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
10. EUROPEAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
11. EUROPEAN PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
12. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
13. ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
14. REST OF THE WORLD PROSTATE CANCER THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY THERAPY, 2018-2025 ($ MILLION)
1. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SHARE BY THERAPY, 2018 VS 2025 (%)
2. GLOBAL PROSTATE CANCER THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
3. US PROSTATE CANCER THERAPEUTICS SIZE, 2018-2025 ($ MILLION)
4. CANADA PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
5. UK PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
6. FRANCE PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
7. GERMANY PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
8. ITALY PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
9. SPAIN PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
10. ROE PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
11. INDIA PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
12. CHINA PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
13. JAPAN PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
14. REST OF ASIA-PACIFIC PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF THE WORLD PROSTATE CANCER THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)